MMP9 as marker of endometrial cancer

Eva Colas (Inventor), Jaume Reventos (Inventor), Elena Martinez Garcia (Inventor), Bruno Domon (Inventor), Antoine Lesur (Inventor)

    Research output: Patent


    The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.
    Original languageEnglish
    IPCWO 2017/190896
    Publication statusPublished - 9 Nov 2017


    Dive into the research topics of 'MMP9 as marker of endometrial cancer'. Together they form a unique fingerprint.

    Cite this